Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials
Surgery and radiotherapy are considered as standard treatments in every risk groups of localized prostate cancer. Regarding radiotherapy, it is well established that dose escalation improves biochemical-progression-free survival (b-PFS) and less likely overall survival (OS) [1 –3].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Daniel Lam Cham Kee, Jocelyn Gal, Alexander T. Falk, Renaud Schiappa, Marie-Eve Chand, Mathieu Gautier, J érôme Doyen, Jean-Michel Hannoun-levi Tags: Systematic or Meta-analysis Studies Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Study